FIELD: medicine.
SUBSTANCE: invention relates to field of molecular biology, clinical biochemistry, medicine, veterinary, pharmacology, endocrinology and oncology. To diagnose prostate cancer, patient's blood is sampled. Sample preparation of blood is performed aimed at its deproteinisation. Sedimentation of proteins from analysed fluid is carried out with methanol, after which direct mass-spectrometric analysis of fractions of analysed substances - markers - is carried out by quadrupole-time-of-flight mass-spectrometry.
EFFECT: method makes it possible to diagnose prostate cancer.
1 dwg, 3 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
MARKER OF PROSTATE GLAND CANCER | 2007 |
|
RU2360924C1 |
METHOD OF DETERMINING THE RISK OF MALIGNANT TRANSFORMATION OF PROSTATE CELLS | 2022 |
|
RU2806518C1 |
REAGENT KIT FOR DETECTING A MARKER OF EPITHELIAL CARCINOMAS | 2018 |
|
RU2735918C2 |
METHOD OF DIFFERENTIAL DIAGNOSIS OF PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA | 2016 |
|
RU2647433C1 |
METHOD OF DIFFERENTIAL DIAGNOSIS OF PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA | 2016 |
|
RU2646790C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR PROSTATE CANCER | 2011 |
|
RU2469333C1 |
METHOD OF DIAGNOSING HEART FAILURE WITH PRESERVED EJECTION FRACTION | 2023 |
|
RU2814392C1 |
METHOD OF PRE-OPERATIVE PREDICTION OF STAGE AND AGGRESSIVENESS OF PROSTATE CANCER | 2015 |
|
RU2611380C2 |
METHOD FOR DETECTING SOLID MALIGNANT TUMOR | 2015 |
|
RU2720148C2 |
METHOD FOR PROSTATE CANCER STAGE AND AGGRESSIVENESS PREDICTION PRIOR TO SURGERY, BASED ON LABORATORY AND CLINICAL PARAMETERS | 2015 |
|
RU2614501C1 |
Authors
Dates
2012-03-20—Published
2010-03-22—Filed